|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,839.85 INR | +2.40% |
|
+7.68% | +15.57% |
| 15/05 | Hester Biosciences Limited, Q4 2026 Earnings Call, May 15, 2026 | |
| 15/05 | Hester Biosciences' Consolidated Profit Soars in Fiscal Q4; Shares Jump 10% | MT |
| Capitalization | 1.07TCr 11Cr 9.57Cr 8.77Cr 8.28Cr 15Cr 16Cr 104.46Cr 41Cr 505.65Cr 42Cr 41Cr 1.77TCr | P/E ratio 2024 |
62.6x | P/E ratio 2025 | 38.8x |
|---|---|---|---|---|---|
| Enterprise value | 1.29TCr 13Cr 11Cr 11Cr 9.95Cr 18Cr 19Cr 125.51Cr 49Cr 607.51Cr 50Cr 49Cr 2.12TCr | EV / Sales 2024 |
4.53x | EV / Sales 2025 | 4.11x |
| Free-Float |
31.21% | Yield 2024 |
0.43% | Yield 2025 | 0.56% |
Last Transcript: Hester Biosciences Limited
| 1 day | +2.40% | ||
| 1 week | +7.68% | ||
| Current month | +12.30% | ||
| 1 month | +24.55% | ||
| 3 months | +17.91% | ||
| 6 months | +8.63% | ||
| Current year | +15.57% |
| 1 week | 1,675 |  | 1,997.95 |
| 1 month | 1,454 | | 1,997.95 |
| Current year | 1,250.95 | | 1,997.95 |
| 1 year | 1,250.95 | | 2,347.7 |
| 3 years | 1,246.75 | | 3,375.45 |
| 5 years | 1,246.75 | | 3,375.45 |
| 10 years | 611 | | 3,375.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 29/04/1987 | |
Ashish Desai
DFI | Director of Finance/CFO | - | 20/11/2025 |
Vinod Mali
CMP | Compliance Officer | - | 14/05/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 83 | 21/04/2005 | |
| Director/Board Member | 63 | 29/04/1987 | |
| Director/Board Member | 61 | 29/04/1987 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.40% | +7.68% | +3.92% | +7.40% | 16Cr | |
| +1.54% | +2.57% | -51.86% | -56.05% | 3.31TCr | |
| -0.65% | -7.61% | +49.77% | +132.67% | 988.91Cr | |
| -2.92% | -8.98% | +17.44% | +43.47% | 526.76Cr | |
| +1.13% | +5.43% | +15.04% | +17.48% | 345.31Cr | |
| -0.63% | -7.33% | +97.77% | +32.58% | 227.17Cr | |
| +0.50% | -0.66% | -26.09% | -4.50% | 167.23Cr | |
| -0.82% | -7.33% | +40.49% | +140.43% | 137.51Cr | |
| -0.46% | -3.27% | -30.54% | -12.93% | 114.46Cr | |
| +1.13% | -2.32% | +1.41% | -45.02% | 107.49Cr | |
| Average | -0.02% | -1.75% | +11.73% | +25.55% | 593.92Cr | |
| Weighted average by Cap. | -0.27% | -0.64% | -14.79% | -0.93% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 311.19Cr 3.21Cr 2.77Cr 2.54Cr 2.4Cr 4.42Cr 4.54Cr 30Cr 12Cr 146.5Cr 12Cr 12Cr 511.55Cr | 312.47Cr 3.23Cr 2.78Cr 2.55Cr 2.41Cr 4.44Cr 4.55Cr 30Cr 12Cr 147.1Cr 12Cr 12Cr 513.66Cr |
| Net income | 19Cr 19.51L 16.83L 15.41L 14.57L 26.85L 27.53L 1.84Cr 71.54L 8.89Cr 73.21L 71.65L 31Cr | 27Cr 28.39L 24.49L 22.43L 21.2L 39.08L 40.06L 2.67Cr 1.04Cr 13Cr 1.07Cr 1.04Cr 45Cr |
| Net Debt | 229.07Cr 2.37Cr 2.04Cr 1.87Cr 1.77Cr 3.26Cr 3.34Cr 22Cr 8.68Cr 107.84Cr 8.88Cr 8.69Cr 376.56Cr | 216.39Cr 2.24Cr 1.93Cr 1.77Cr 1.67Cr 3.08Cr 3.15Cr 21Cr 8.2Cr 101.87Cr 8.39Cr 8.21Cr 355.71Cr |
Employees
562
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/26/20 | 1,839.85 ₹ | +2.40% | 546 |
| 19/26/19 | 1,796.75 ₹ | +1.49% | 1,030 |
| 18/26/18 | 1,770.30 ₹ | -3.48% | 1,217 |
| 15/26/15 | 1,834.05 ₹ | +5.67% | 6,025 |
| 14/26/14 | 1,735.65 ₹ | +1.58% | 484 |
Annual profits - Rate of surprise
- Stock Market
- Equities
- 524669 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition